H. Gilbert Welch, a health policy expert who has advocated against superfluous cancer screening, published another Dartmouth researcher’s work, according to the university administration.

3-D balls of cells can be used to screen for potential cancer drugs.

Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.

The new diagnostic works by identifying cancer-associated proteins and DNA in patient blood.